News tagged with prednisone
Shorter duration steroid therapy may offer similar effectiveness in reducing COPD exacerbations
Among patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) requiring hospital admission, a 5-day glucocorticoid treatment course was non-inferior (not worse than) to a 14-day course with regard ...
Diseases, Conditions, Syndromes
May 21, 2013 |
not rated yet |
0
Study shows additional role for abiraterone in blocking tumor growth in CRPC
As part of an EU-supported IMI-PREDECT consortium (http://www.predect.eu), a Dutch study showed that anti-androgenic properties of the drug abiraterone may provide an additional mechanism of action in blocking tumour growth of ca ...
Cancer
Mar 15, 2013 |
not rated yet |
0
Abiraterone benefits chemo-naive with advanced prostate CA
(HealthDay)—For chemotherapy-naive patients with metastatic castration-resistant prostate cancer, abiraterone acetate correlates with improved radiographic progression-free survival, according to a study ...
Cancer
Dec 12, 2012 |
not rated yet |
0
FDA OKs expanded use of prostate cancer drug
(HealthDay)—The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate cancer before they undergo chemotherapy, the U.S. Food ...
Medications
Dec 10, 2012 |
not rated yet |
0
Phase 3 trial confirms abiraterone acetate efficacy for patients with advanced prostate cancer
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer ...
Cancer
Sep 17, 2012 |
not rated yet |
0
Hepatitis B screening before chemo deemed cost-effective
(HealthDay) -- Universal hepatitis B virus (HBV) screening before chemotherapy for lymphoma reduces costs in most settings, according to a study published online June 18 in the Journal of Clinical Oncology.
Cancer
Jun 20, 2012 |
not rated yet |
0
Liver metastases and its prognostic significance in men with metastatic prostate cancer
Liver metastases predicts shorter overall survival in men with metastatic castration-refractory prostate cancer (mCRPC), according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in ...
Cancer
May 31, 2012 |
not rated yet |
0
Cabazitaxel can offer an advantage in certain patients
Cabazitaxel (trade name: Jevtana) has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic ...
Cancer
May 29, 2012 |
not rated yet |
0
Bevacizumab doesn't up overall survival in prostate cancer
(HealthDay) -- For men with metastatic castration-resistant prostate cancer (mCRPC), the addition of bevacizumab (B) to docetaxel plus prednisone (DP) is not associated with improved overall survival (OS), ...
Cancer
Mar 27, 2012 |
not rated yet |
0
Abiraterone: Indication of considerable added benefit in certain patients
Abiraterone (trade name: Zytiga) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic ...
Medications
Jan 06, 2012 |
not rated yet |
0
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Cancer
Nov 24, 2011 |
not rated yet |
0
Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
Stockholm, Sweden: Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, ...
Cancer
Sep 25, 2011 |
not rated yet |
0
Etanercept shows promise for treating dermatomyositis
A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy. These results are encouraging, ...
Neuroscience
Jun 17, 2011 |
not rated yet |
0
Injection therapy for sudden hearing loss disorder may be suitable alternative to oral steroids
Treating idiopathic sudden sensorineural hearing loss with injections of steroids directly into the ear appears to result in recovery of hearing that is not less than recovery obtained with the standard therapy of oral corticosteroids ...
Diseases, Conditions, Syndromes
May 25, 2011 |
not rated yet |
0
African-Americans with SLE more responsive to flu vaccine than patients of European descent
New research shows that African Americans with systemic lupus erythematosus (SLE) had a higher antibody response to influenza vaccination than European American patients. Treatment with prednisone, a history of hemolytic ...
Diseases, Conditions, Syndromes
May 19, 2011 |
not rated yet |
0
- Pages: 1
Prednisone
Prednisone is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug. It is used to treat certain inflammatory diseases and (at higher doses) some types of cancer, but has significant adverse effects. Because it suppresses the immune system, it leaves patients more susceptible to infections.
It is usually taken orally but can be delivered by intramuscular injection or intravenous injection. It has a mainly glucocorticoid effect. Prednisone is a prodrug that is converted by the liver into prednisolone, which is the active drug and also a steroid.
For more information about Prednisone, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
